某三甲医院2012—2016年国家基本药物使用情况分析

Analysis of the utilization of national essential medicines in a “Three-A” hospital from 2012 to 2016

目的通过对某三甲医院近5年来国家基本药物使用及不良反应发生情况进行统计分析,为促进临床优先、合理、安全使用国家基本药物提供参考。方法利用该院信息系统(HIS)药品销售报表、该院上报不良反应监测网不良反应情况等信息,通过Excel表进行统计分析。结果该院国家基本药物品种配备数占比每年均在50%～60%之间;销售金额占比在14%～17%之间;销售额排名前3位的化学药品分别为调节水、电解质及酸碱平衡药、血液系统用药、激素及影响内分泌药,中成药类国家基本药物以内科用药为主,其中理血剂使用金额为最高; 2012年度国家不良反应发生率占比最高,达80%,其他年份在30%左右。结论该院基本药物覆盖率、使用金额等与国家卫生部门要求尚有一定差距,建议该院适当加大国家基本药物特别是中成药的引进力度,加强对优先使用国家基本药物的宣传并通过适当措施促进临床合理使用国家基本药物。

Objective In a third-grade class-A hospital,the use of national essential medicines and the occurrence of adverse reactions in the past five years were calculated and analyzed,to provide reference for the the priority,reasonable and safe clinical use of national essential medicines.Methods Based on the drug sales report in the hospital′s information system(HIS)and the hospital reported adverse reaction of the monitoring network,the statistical analysis was carried out through the excel chart.Results The proportion of the national essential medicines was between 50%and 60%.The proportion of national essential medicines′s sales amount was between 14%and 17%every year.The top three chemicals in sales were medicine for adjusting the water,electrolyte and acid-base,blood system,hormones and endocrine.Internal medicines were the main components in Chinese medicines and the sales of treating blood disorder agent was the highest.The rate of adverse reactions about national essential medicines was the highest in 2012,which reached up to 80%.The rate of other years was around 30%.Conclusion Compared with the requirements of the national health department,there was a gap in the coverage and use amount of national essential medicines.It is suggested that the hospital should increase the introduction of national essential medicines,especially the Chinese medicines,strengthen the propaganda of the priority use of national essential medicines and promote the rational use of national essential medicines through appropriate measures.